Sunteți pe pagina 1din 2

Atlas Biologicals Awarded $2.04M in Federal Court vs.

Former Employee
Thomas Kutrubes, Peak Serum, Inc.; Peak Serum, Inc. Files Bankruptcy

Fort Collins, CO-based biotechnology firm Atlas Biologicals has been awarded $2.04M in a case
versus former employee Thomas Kutrubes and Peak Serum, Inc. The judgment states Kutrubes
allegedly set up Peak Serum, Inc. secretly while still employed at Atlas Biologicals, then gathered
and used trade secrets, marketing collateral, customer databases, and other intellectual property
without company knowledge or approval.

Fort Collins, CO, November 26, 2019 --(PR.com)-- Atlas Biologicals, a privately-held firm located in
Fort Collins, CO, has been awarded $2.04M in damages in a legal case versus their former employee,
Thomas Kutrubes, CEO of Peak Serum, Inc.

The judgment stems from allegations that Kutrubes allegedly stole trade secrets, intellectual property,
customer contact lists, branding, and formulations from Atlas Biologicals, setting up a new company
while still employed there, and using these to advantage in his new company, including claim of
operating as a “sister company" to Atlas. It was also alleged that Peak had falsified labels and exported
mislabeled serum products. The case (Civil Action No. 15-cv-00355-CMA-KMT) was presided over in
the US District Court for the State of Colorado by Judge Christine M. Arguello.

Judgment was finalized on September 23, 2019 in Atlas Biologicals' favor and Kutrubes is required to
compensate Atlas Biologicals in the amount of $2.04M. As of November 13, 2019, Peak Serum, Inc. filed
for Chapter 11 Bankruptcy.

Atlas Biologicals was founded by Richard (“Rick”) Paniccia and Brent Bearden in 1998 and both remain
majority owners as of 2019.

Atlasbio.com
Media: Dawn Duncan, Yellowbright, Inc., 970.980.6399, dawn@yellowbrightinc.com

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Yellowbright, Inc.
Dawn Marie Duncan
970-980-6399
Contact via Email
yellowbrightinc.com
dawn@yellowbrightinc.com
michelle@atlasbio.com

Online Version of Press Release:


You can read the online version of this press release at: https://www.pr.com/press-release/800117

Page 2/2
PR.com Press Release Distribution Terms of Use

S-ar putea să vă placă și